Don't Say That Word | home 
Asprin may prevent prostate cancer
Taking an aspirin each day is good not only for the heart, but it may also reduce the risk of prostate cancer. Previous reports investigating the anti-cancer effects of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have yielded conflicting results. For this reason, researchers from from McGill University, Montreal analysed combined data from 12 reports to clarify the effect of these drugs on the risk of prostate cancer.
NSAIDs (and aspirin in particular) appear to offer some protective effect against prostate cancer both in laboratory studies and in observational studies in humans. The use of aspirin was associated with a 30 percent reduction in the risk of advanced prostate cancer and a 10 percent reduction in total prostate cancer risk.
The study reported a strong anti-cancer effect for aspirin use, but only among participants that had taken aspirin for at least 4 years. Therefore it is too early to recommend regular use of aspirin for prostate cancer prevention, but the time is right for looking into studies specifically designed to address this topic. Recently, two large randomised controlled trials have begun to evaluate the protective effects of the newer NSAIDs. The focus is on newer NSAIDs because they have fewer side effects, such as stomach bleeding etc. and they are more profitable for drug companies.
|